身体成分改变与2型糖尿病进展的相关性研究进展
Research Progress on Correlation between Body Composition Changes and Disease Pro-gression of Type 2 Diabetes
摘要: 随着现代生活饮食方式,人口结构等因素的影响,以糖尿病为首的慢性疾病患病率逐年上升,严重影响生活质量,为医疗卫生系统带来重大负担。糖尿病人群中,2型糖尿病人群占主要比例。已有大量研究证明:糖尿病与肥胖的关系密不可分,糖尿病与肥胖互为影响,糖尿病作为肥胖的代谢并发症之一,肥胖会导致胰岛素抵抗,进而进展为糖尿病。既往研究中,大多使用体质指数(BMI)定义肥胖,近年来多项研究发现,2型糖尿病患者的身体成分变化与糖尿病进展有重要关系,其中人体脂肪含量与骨骼肌含量的占比影响尤为显著,然而BMI无法明确区分人体成分中肌肉占比与脂肪占比,也无法区分体内脂肪在全身各脏器的分布。使用BMI定义肥胖得出的结果偏低,对于评估糖尿病患者的疾病进展有相对局限性。测量2型糖尿病患者的各项人体占比,对于进一步评估疾病分期,延缓疾病进展以及制定个体化治疗方案提供新思路,本文就国内外身体成分改变与2型糖尿病进展相关文献研究作一综述。
Abstract: With the influence of modern lifestyle, diet, population structure and other factors, the incidence of chronic diseases led by diabetes is increasing year by year, which seriously affects the quality of life and brings a major burden to the medical and health system. Type 2 diabetes accounts for the ma-jority of the diabetes population. A large number of studies have proved that the relationship be-tween diabetes and obesity is inseparable, and diabetes and obesity influence each other. As one of the metabolic complications of obesity, diabetes will lead to insulin resistance, and then progress to diabetes. Most of the previous studies used body mass index (BMI) to define obesity. In recent years, a number of studies have found that the change of body composition in type 2 diabetes patients has an important relationship with the progression of diabetes, in which the proportion of body fat con-tent and skeletal muscle content has a particularly significant impact. However, BMI cannot clearly distinguish the proportion of muscle and fat in body composition. It is also unable to distinguish the distribution of body fat in various organs throughout the body. Using BMI to define obesity yields low results and is relatively limited for assessing disease progression in patients with diabetes. The measurement of various body proportions in patients with type 2 diabetes provides new ideas for further assessing disease stages, delaying disease progression, and developing individualized treatment plans. This article reviews the literature on the relationship between changes in body composition and progression of type 2 diabetes at home and abroad.
文章引用:张敏, 艾比拜·玉素甫. 身体成分改变与2型糖尿病进展的相关性研究进展[J]. 临床医学进展, 2024, 14(3): 936-946. https://doi.org/10.12677/ACM.2024.143794

参考文献

[1] Tinajero, M.G. and Malik, V.S. (2021) An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective. En-docrinology and Metabolism Clinics of North America, 50, 337-355. [Google Scholar] [CrossRef] [PubMed]
[2] Vijan, S. (2019) Type 2 Diabetes. Annals of Internal Medicine, 171, ITC65-ITC80. [Google Scholar] [CrossRef
[3] Nishikawa, H., Fukunishi, S., Asai, A., et al. (2021) Sarcopenia, Frailty and Type 2 Diabetes Mellitus (Review). Molecular Medicine Reports, 24, Article No. 854. [Google Scholar] [CrossRef] [PubMed]
[4] Purnamasari, D., Tetrasiwi, E.N., Kartiko, G.J., et al. (2022) Sarco-penia and Chronic Complications of Type 2 Diabetes Mellitus. The Review of Diabetic Studies, 18, 157-165. [Google Scholar] [CrossRef
[5] 杨海燕, 葛声. 骨骼肌质量指数与2型糖尿病相关性研究[C]//中国营养学会, 中国学生营养与健康促进会. 第七届海峡两岸暨港澳营养科学大会摘要集. 2022: 103-104.
[6] Jeon, Y.G., Kim, Y.Y., Lee, G., et al. (2023) Physiological and Pathological Roles of Lipogenesis. Na-ture Metabolism, 5, 735-759. [Google Scholar] [CrossRef] [PubMed]
[7] Boutari, C., DeMarsilis, A. and Mantzoros, C.S. (2023) Obesity and Diabetes. Diabetes Research and Clinical Practice, 202, Article ID: 110773. [Google Scholar] [CrossRef] [PubMed]
[8] Klein, S., Gastaldelli, A., Yki-Järvinen, H. and Scherer, P.E. (2022) Why Does Obesity Cause Diabetes? Cell Metabolism, 34, 11-20. [Google Scholar] [CrossRef] [PubMed]
[9] Akinjinmi, A.A., Amballi, A.A., Opeyemi, A.A., et al. (2023) Re-lationship between Serum Leptin, Lipid Metabolism, HbA1c, and Renal Function in Individuals with Type 2 Diabetes Mellitus and Obesity and in Individuals with Type 2 Diabetes Mellitus without Obesity. [Google Scholar] [CrossRef
[10] Fogarasi, A., Gonzalez, K., Dalamaga, M., et al. (2022) The Impact of the Rate of Weight Loss on Body Composition and Metabolism. Current Obesity Reports, 11, 33-44. [Google Scholar] [CrossRef] [PubMed]
[11] Guarnieri Lopez, M., Matthes, K.L., Sob, C., et al. (2023) Asso-ciations between 3D Surface Scanner Derived Anthropometric Measurements and Body Composition in a Cross-Sectional Study. European Journal of Clinical Nutrition, 77, 972-981. [Google Scholar] [CrossRef] [PubMed]
[12] Guarnieri Lopez, M., Matthes, K.L., Sob, C., et al. (2023) Asso-ciations between 3D Surface Scanner Derived Anthropometric Measurements and Body Composition in a Cross-Sectional Study. European Journal of Clinical Nutrition, 77, 972-981. [Google Scholar] [CrossRef] [PubMed]
[13] Lee, B.J. and Yim, M.H. (2021) Comparison of Anthropometric and Body Composition Indices in the Identification of Metabolic Risk Factors. Scientific Reports, 11, Article No. 9931. [Google Scholar] [CrossRef] [PubMed]
[14] Gupta, P., Lanca, C., Gan, A.T.L., et al. (2019) The Association between Body Composition Using Dual Energy X-Ray Absorptiometry and Type-2 Diabetes: A Systematic Review and Meta-Analysis of Observational Studies. Scientific Reports, 9, Article No. 12634. [Google Scholar] [CrossRef] [PubMed]
[15] Misnikova, I.V., Kovaleva, Y.A., Polyakova, E.Y., et al. (2021) Assessment of Muscle and Fat Mass in Type 2 Diabetes Patients by Dual-Energy X-Ray Absorptiometry. Journal of Musculoskeletal & Neuronal Interactions, 21, 364-372.
[16] Chianca, V., Albano, D., Messina, C., et al. (2022) Sarco-penia: Imaging Assessment and Clinical Application. Abdominal Radiology, 47, 3205-3216. [Google Scholar] [CrossRef] [PubMed]
[17] Sbrignadello, S., Göbl, C. and Tura, A. (2022) Bioelectrical Im-pedance Analysis for the Assessment of Body Composition in Sarcopenia and Type 2 Diabetes. Nutrients, 14, Article 1864. [Google Scholar] [CrossRef] [PubMed]
[18] Guedes, D.P., Calabrese, J.C. and Pirolli, P.M. (2019) Use of Dif-ferent Segmental Multi-Frequency Bioelectrical Impedance Devices for Analysis of Body Composition in Young Adults: Comparison with Bioelectrical Spectroscopy. Nutricion Hospitalaria, 36, 618-625. [Google Scholar] [CrossRef] [PubMed]
[19] Bell, K.E., Paris, M.T., Avrutin, E. and Mourtzakis, M. (2022) Altered Fea-tures of Body Composition in Older Adults with Type 2 Diabetes and Prediabetes Compared with Matched Controls. Journal of Cachexia, Sarcopenia and Muscle, 13, 1087-1099. [Google Scholar] [CrossRef] [PubMed]
[20] Ruiz, H.H., López Díez, R., Arivazahagan, L., et al. (2019) Metabolism, Obesity, and Diabetes Mellitus. Arteriosclerosis, Throm-bosis, and Vascular Biology, 39, E166-E174. [Google Scholar] [CrossRef
[21] Zheng, B., Zheng, Y., Zhang, Y., et al. (2023) Precedence of Bone Loss Accompanied with Changes in Body Composition and Body Fat Distribution in Patients with Type 2 Diabetes Mellitus. Journal of Diabetes Research, 2023, Article ID: 6753403. [Google Scholar] [CrossRef] [PubMed]
[22] Li, Q., Wang, O., Ji, B., et al. (2023) Alcohol, White Adipose Tissue, and Brown Adipose Tissue: Mechanistic Links to Lipogenesis and Lipolysis. Nutrients, 15, Article 2953. [Google Scholar] [CrossRef] [PubMed]
[23] 许琳. 糖尿病的形成机理(病因)及其临床诊断标准[J]. 基因组学与应用生物学, 2021, 40(3): 1426-1429.
[24] Weir, G.C. (2020) Glucolipotoxicity, β-Cells, and Diabetes: The Emperor Has No Clothes. Diabetes, 69, 273-278. [Google Scholar] [CrossRef] [PubMed]
[25] Zamboni, M., Nori, N., Brunelli, A. and Zoico, E. (2021) How Does Adi-pose Tissue Contribute to Inflammageing? Experimental Gerontology, 143, Article ID: 111162. [Google Scholar] [CrossRef] [PubMed]
[26] Stranahan, A.M. (2022) Visceral Adiposity, Inflammation, and Hippocampal Function in Obesity. Neuropharmacology, 205, Article ID: 108920. [Google Scholar] [CrossRef] [PubMed]
[27] Straub, L.G. and Scherer, P.E. (2019) Metabolic Messen-gers: Adiponectin. Nature Metabolism, 1, 334-339. [Google Scholar] [CrossRef] [PubMed]
[28] Castaño, C., Novials, A. and Párrizas, M. (2019) Exosomes and Diabetes. Diabetes/Metabolism Research and Reviews, 35, e3107. [Google Scholar] [CrossRef] [PubMed]
[29] Jiang, S., Young, J.L., Wang, K., et al. (2020) Diabetic-Induced Alterations in Hepatic Glucose and Lipid Metabolism: The Role of Type 1 and Type 2 Diabetes Mellitus (Review). Molecular Medicine Reports, 22, 603-611. [Google Scholar] [CrossRef] [PubMed]
[30] Rojano-Toimil, A., Rivera-Esteban, J., Manzano-Nuñez, R., et al. (2022) When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD. Journal of Clinical Medicine, 11, Article 3286. [Google Scholar] [CrossRef] [PubMed]
[31] Salom Vendrell, C., García Tercero, E., Moro Hernández, J.B., et al. (2023) Sarcopenia as a Little-Recognized Comorbidity of Type II Diabetes Mellitus: A Review of the Diagnosis and Treatment. Nutrients, 15, Article 4149. [Google Scholar] [CrossRef] [PubMed]
[32] Anagnostis, P., Gkekas, N.K., Achilla, C., et al. (2020) Type 2 Diabetes Mellitus Is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-Analysis. Calcified Tissue In-ternational, 107, 453-463. [Google Scholar] [CrossRef] [PubMed]
[33] Massimino, E., Izzo, A., Riccardi, G., et al. (2021) The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms. Cells, 10, Article 1958. [Google Scholar] [CrossRef] [PubMed]
[34] Park, J.H., Lee, M.Y., Shin, H.K., et al. (2023) Lower Skeletal Muscle Mass Is Associated with Diabetes and Insulin Resistance: A Cross-Sectional Study. Diabetes/Metabolism Research and Reviews, 39, e3681. [Google Scholar] [CrossRef] [PubMed]
[35] Jun, J.E., Lee, S.E., Lee, Y.B., et al. (2023) Low Skeletal Muscle Mass Accompanied by Abdominal Obesity Additively Increases the Risk of Incident Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism, 108, 1173-1180. [Google Scholar] [CrossRef] [PubMed]
[36] Tian, J., Fan, J. and Zhang, T. (2023) Mitochondria as a Target for Exercise-Mitigated Type 2 Diabetes. Journal of Molecular Histology, 54, 543-557. [Google Scholar] [CrossRef] [PubMed]
[37] Yang, M., Luo, S., Yang, J., et al. (2022) Myokines: Novel Therapeutic Targets for Diabetic Nephropathy. Frontiers in Endocrinology, 13, Article 1014581. [Google Scholar] [CrossRef] [PubMed]
[38] Dumond Bourie, A., Potier, J.B., Pinget, M., et al. (2023) My-okines: Crosstalk and Consequences on Liver Physiopathology. Nutrients, 15, Article 1729. [Google Scholar] [CrossRef] [PubMed]
[39] Zhang, L., Lv, J., Wang, C., et al. (2023) Myokine, a Key Cytokine for Physical Exercise to Alleviate Sarcopenic Obesity. Molecular Biology Reports, 50, 2723-2734. [Google Scholar] [CrossRef] [PubMed]
[40] Løvsletten, N.G., Rustan, A.C., Laurens, C., et al. (2020) Pri-mary Defects in Lipid Handling and Resistance to Exercise in Myotubes from Obese Donors with and without Type 2 Diabetes. Applied Physiology, Nutrition, and Metabolism, 45, 169-179. [Google Scholar] [CrossRef] [PubMed]
[41] Zhang, M., Qin, L., Qin, Y., et al. (2023) 287-LB: Thiazolidinedione Ameliorates Lipotoxicity-Induced Pancreatic ß-Cell Ferroptosis Partly via ACSL4. Diabetes, 72, 287-LB. [Google Scholar] [CrossRef
[42] Alizadeh Pahlavani, H. (2022) Exercise Therapy for People with Sar-copenic Obesity: Myokines and Adipokines as Effective Actors. Frontiers in Endocrinology, 13, Article 811751. [Google Scholar] [CrossRef] [PubMed]
[43] Zhang, C., Luo, X., Zhang, D., et al. (2020) Hypoxic Adipocytes Induce Macrophages to Release Inflammatory Cytokines That Render Skeletal Muscle Cells Insulin Resistant. Biochemi-cal and Biophysical Research Communications, 521, 625-631. [Google Scholar] [CrossRef] [PubMed]
[44] Fang, P., She, Y., Yu, M., et al. (2023) Adipose-Muscle Crosstalk in Age-Related Metabolic Disorders: The Emerging Roles of Adipo-Myokines. Ageing Research Reviews, 84, Article ID: 101829. [Google Scholar] [CrossRef] [PubMed]
[45] Di Leo, V., Bernardino Gomes, T.M. and Vincent, A.E. (2023) In-teractions of Mitochondrial and Skeletal Muscle Biology in Mitochondrial Myopathy. Biochemical Journal, 480, 1767-1789. [Google Scholar] [CrossRef
[46] Eshima, H. (2021) Influence of Obesity and Type 2 Diabe-tes on Calcium Handling by Skeletal Muscle: Spotlight on the Sarcoplasmic Reticulum and Mitochondria. Frontiers in Physiology, 12, Article 758316. [Google Scholar] [CrossRef] [PubMed]
[47] Abrigo, J., Simon, F., Cabrera, D., et al. (2019) Mitochondrial Dysfunction in Skeletal Muscle Pathologies. Current Protein & Peptide Science, 20, 536-546. [Google Scholar] [CrossRef] [PubMed]
[48] De Mario, A., Gherardi, G., Rizzuto, R. and Mammu-cari, C. (2021) Skeletal Muscle Mitochondria in Health and Disease. Cell Calcium, 94, Article ID: 102357. [Google Scholar] [CrossRef] [PubMed]
[49] Wang, M., Pu, D., Zhao, Y., et al. (2020) Sulforaphane Protects against Skeletal Muscle Dysfunction in Spontaneous Type 2 Diabetic Db/Db Mice. Life Sciences, 255, Article ID: 117823. [Google Scholar] [CrossRef] [PubMed]
[50] Haase, C.B., Brodersen, J.B. and Bülow, J. (2022) Sarco-penia: Early Prevention or Overdiagnosis? The BMJ, 376, e052592. [Google Scholar] [CrossRef] [PubMed]
[51] Matsuura, S., Shibazaki, K., Uchida, R., et al. (2022) Sarcopenia Is Associated with the Geriatric Nutritional Risk Index in Elderly Patients with Poorly Controlled Type 2 Diabetes Mellitus. Journal of Diabetes Investigation, 13, 1366-1373. [Google Scholar] [CrossRef] [PubMed]
[52] Lombardo, M., Boaria, A., Aulisa, G., et al. (2019) Sarcopenic Obesity: Etiology and Lifestyle Therapy. European Review for Medical and Phar-macological Sciences, 23, 7152-7162.
[53] Sohi, Y.H., Golestani, A., Panahi, G., et al. (2023) The Association between Anti-Diabetic Agents and Osteoporosis, Sarcopenia, and Osteosarcopenia among Iranian Older Adults; Bushehr Elderly Health (BEH) Program. DARU Journal of Pharmaceutical Sciences. [Google Scholar] [CrossRef] [PubMed]
[54] Hong, S.H. and Choi, K.M. (2020) Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. International Journal of Molecular Sciences, 21, Article 494. [Google Scholar] [CrossRef] [PubMed]
[55] Lynch, G.M., Murphy, C.H., Castro, E., De, M., et al. (2020) Inflam-mation and Metabolism: The Role of Adiposity in Sarcopenic Obesity. The Proceedings of the Nutrition Society, 79, 435-447. [Google Scholar] [CrossRef
[56] Zhu, M., Liu, X., Liu, W., et al. (2021) β Cell Aging and Age-Related Diabetes. Aging, 13, 7691-7706. [Google Scholar] [CrossRef] [PubMed]
[57] Aguayo-Mazzucato, C., Andle, J., Lee, T.B., et al. (2019) Acceleration of β Cell Aging Determines Diabetes and Senolysis Improves Disease Outcomes. Cell Metabolism, 30, 129-142.E4. [Google Scholar] [CrossRef] [PubMed]
[58] Dilworth, L., Facey, A. and Omoruyi, F. (2021) Diabetes Mellitus and Its Metabolic Complications: The Role of Adipose Tissues. International Journal of Molecular Sciences, 22, Article 7644. [Google Scholar] [CrossRef] [PubMed]
[59] Norman, K. and Herder, C. (2019) Sarkopene Adipositas Und Inflammation. Der Diabetologe, 15, 311-317. [Google Scholar] [CrossRef
[60] Wen, J., Cai, X., Zhang, J., et al. (2020) Relation of Adipose Tis-sue Insulin Resistance to Prediabetes. Endocrine, 68, 93-102. [Google Scholar] [CrossRef] [PubMed]
[61] Kurinami, N., Sugiyama, S., Yoshida, A., et al. (2021) Body Muscle-to-Fat Ratio, Rather than Fat-to-Muscle Ratio, Significantly Correlates with Measured Insulin Resistance in Pa-tients with Type 2 Diabetes Mellitus. Journal of Clinical Medicine Research, 13, 387-391. [Google Scholar] [CrossRef] [PubMed]
[62] Kurinami, N., Sugiyama, S., Yoshida, A., et al. (2019) Body Mus-cle-to-Fat Ratio Gender-Specific Cut-Off Values for Impaired Insulin Sensitivity in Patients with Treatment-Naïve Type 2 Diabetes Mellitus. Endocrine, 66, 503-508. [Google Scholar] [CrossRef] [PubMed]
[63] Al-Sofiani, M.E., Ganji, S.S. and Kalyani, R.R. (2019) Body Composition Changes in Diabetes and Aging. Journal of Diabetes and Its Complications, 33, 451-459. [Google Scholar] [CrossRef] [PubMed]
[64] Roh, E., Hwang, S.Y., Kim, J.A., et al. (2021) Age- and Sex-Related Differential Associations between Body Composition and Diabetes Mellitus. Diabetes & Metabolism Jour-nal, 45, 183-194. [Google Scholar] [CrossRef] [PubMed]
[65] De Ritter, R., Sep, S.J.S., Van Greevenbroek, M.M.J., et al. (2023) Sex Differences in Body Composition in People with Prediabetes and Type 2 Diabetes as Com-pared with People with Normal Glucose Metabolism: The Maastricht Study. Diabetologia, 66, 861-872. [Google Scholar] [CrossRef] [PubMed]
[66] Lin, C.L., Yu, N.C., Wu, H.C., et al. (2021) Association of Body Composition with Type 2 Diabetes: A Retrospective Chart Review Study. International Journal of Environmental Research and Public Health, 18, Article 4421. [Google Scholar] [CrossRef] [PubMed]
[67] Qi, Q., Sun, K., Rong, Y., et al. (2022) Body Composition of the Up-per Limb Associated with Hypertension, Hypercholesterolemia, and Diabetes. Frontiers in Endocrinology, 13, Article 985031. [Google Scholar] [CrossRef] [PubMed]
[68] Deng, F., Wu, W., Fan, X., et al. (2023) Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts. International Journal of Endocrinology, 2023, Article ID: 9926462. [Google Scholar] [CrossRef] [PubMed]